Literature DB >> 1966020

Prenatal benzodiazepine immunosuppression: possible involvement of peripheral benzodiazepine site.

M Schlumpf1, R Parmar, H R Ramseier, W Lichtensteiger.   

Abstract

Treatment of pregnant Long Evans rats with a low dose of diazepam (1.25 mg/kg from gestational day 14-20) produced offspring suffering from suppression of cellular immune responses. Analogous effects were produced by clonazepam, a benzodiazepine (BDZ) with high affinity for the central-type, and Ro 5-4864, a BDZ with selective affinity for the peripheral-type BDZ receptor. Peripheral-type BDZ receptors are found to develop early in fetal life in peripheral organs including primary (thymus) and secondary (spleen) lymphoid organs, in the central nervous system and on immune cells (lymphocytes). In prenatally diazepam-exposed offspring the affinity constant is significantly changed. BDZ and PK 11195 also inhibit mitogen and alloantigen-induced T and B cell proliferation in vitro in adult murine lymphocytes. Diazepam, Ro 5-4864 and PK 11195 were found to be the most active compounds.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1966020     DOI: 10.1159/000457643

Source DB:  PubMed          Journal:  Dev Pharmacol Ther        ISSN: 0379-8305


  4 in total

1.  Alterations in interleukin-6 production by LPS- and Con A-stimulated mixed splenocytes, spleen macrophages and lymphocytes in prenatally diazepam-exposed rats.

Authors:  A A Schreiber; K Frei; W Lichtensteiger; M Schlumpf
Journal:  Agents Actions       Date:  1993-07

2.  The effect of prenatal diazepam exposure on TNF-alpha production by rat splenocytes.

Authors:  A A Schreiber; K Frei; W Lichtensteiger; M Schlumpf
Journal:  Agents Actions       Date:  1993-03

Review 3.  Possible immunosuppressive effects of drug exposure and environmental and nutritional effects on infection and vaccination.

Authors:  H P Huemer
Journal:  Mediators Inflamm       Date:  2015-04-05       Impact factor: 4.711

4.  Diazepam leads to enhanced severity of orthopoxvirus infection and immune suppression.

Authors:  Hartwig P Huemer; Caroline Lassnig; Norbert Nowotny; Eveline U Irschick; Maria Kitchen; Marion Pavlic
Journal:  Vaccine       Date:  2010-07-24       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.